CytomX Therapeutics, Inc. (CTMX)
4.78
+0.38
(+8.64%)
USD |
NASDAQ |
Mar 19, 16:00
4.84
+0.06
(+1.26%)
After-Hours: 07:34
CytomX Therapeutics Market Cap : 813.49M for March 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| REGENXBIO, Inc. | 431.48M |
| ACADIA Pharmaceuticals, Inc. | 3.533B |
| Alnylam Pharmaceuticals, Inc. | 41.26B |
| Savara, Inc. | 1.056B |
| BioMarin Pharmaceutical, Inc. | 10.58B |
Market Cap Related Metrics
| PE Ratio | 525.27 |
| PS Ratio | 8.647 |
| Price to Book Value | 8.216 |
| Price | 4.78 |
| Earnings Yield | 0.19% |
| Normalized PE Ratio | 549.43 |